Tempest Therapeutics, Inc. (TPST) Financials

TPST Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 24.0 million 25.2 million
2023-06-30 30.7 million 25.7 million
2023-03-31 37.3 million 26.4 million
2022-12-31 46.1 million 28.0 million

TPST Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.5 million 563000
2023-06-30 -6.5 million 440000
2023-03-31 -8.3 million 446000
2022-12-31 -6.8 million 428000

TPST Net Income

No data available :(

TPST Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.1 million - 10.5 million
2023-06-30 17.6 million - 11.0 million
2023-03-31 22.9 million - 11.2 million
2022-12-31 31.2 million - 11.7 million

TPST Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 14.1 million
2023-06-30 14.1 million
2023-03-31 13.8 million
2022-12-31 11.5 million

TPST Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 4.2 million 2.4 million -
2023-06-30 117000 4.4 million 3.1 million -
2023-03-31 46000 4.7 million 2.9 million -
2022-12-31 356000 5.8 million 3.1 million -

TPST Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 510000
2023-06-30 - 497000
2023-03-31 - 557000
2022-12-31 - 539000

TPST

Price: $3.69

52 week price:
0.17
9.77

Earnings Per Share: -1.91 USD

P/E Ratio: -1.90

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 5600

Market Capitalization: 79.7 million

Links: